Free Trial

SQZ Biotechnologies (SQZ) Competitors

SQZ Biotechnologies logo
$0.03 0.00 (0.00%)
As of 09/12/2025

SQZ vs. CISS, OP, GVH, USDP, AIRTP, BLDEW, RA, EDRY, HSHP, and IMPPP

Should you be buying SQZ Biotechnologies stock or one of its competitors? The main competitors of SQZ Biotechnologies include C3is (CISS), OceanPal (OP), Globavend (GVH), USD Partners (USDP), Air T (AIRTP), Blade Air Mobility (BLDEW), Brookfield Real Assets Income Fund (RA), EuroDry (EDRY), Himalaya Shipping (HSHP), and Imperial Petroleum (IMPPP). These companies are all part of the "transportation" industry.

SQZ Biotechnologies vs. Its Competitors

SQZ Biotechnologies (NYSE:SQZ) and C3is (NASDAQ:CISS) are both small-cap transportation companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, profitability, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and risk.

38.5% of SQZ Biotechnologies shares are owned by institutional investors. Comparatively, 10.5% of C3is shares are owned by institutional investors. 16.0% of SQZ Biotechnologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

C3is has a net margin of 20.51% compared to SQZ Biotechnologies' net margin of -369.96%. C3is' return on equity of 5.41% beat SQZ Biotechnologies' return on equity.

Company Net Margins Return on Equity Return on Assets
SQZ Biotechnologies-369.96% -119.83% -59.90%
C3is 20.51%5.41%4.07%

SQZ Biotechnologies has a beta of 2.34, meaning that its share price is 134% more volatile than the S&P 500. Comparatively, C3is has a beta of 1.7, meaning that its share price is 70% more volatile than the S&P 500.

In the previous week, C3is had 1 more articles in the media than SQZ Biotechnologies. MarketBeat recorded 1 mentions for C3is and 0 mentions for SQZ Biotechnologies. C3is' average media sentiment score of 1.91 beat SQZ Biotechnologies' score of 0.00 indicating that C3is is being referred to more favorably in the news media.

Company Overall Sentiment
SQZ Biotechnologies Neutral
C3is Very Positive

C3is has higher revenue and earnings than SQZ Biotechnologies. C3is is trading at a lower price-to-earnings ratio than SQZ Biotechnologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SQZ Biotechnologies$18.16M0.05-$79.46M-$2.61-0.01
C3is$36.42M0.06-$2.75M-$18.04-0.13

Summary

C3is beats SQZ Biotechnologies on 8 of the 13 factors compared between the two stocks.

Get SQZ Biotechnologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for SQZ and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SQZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SQZ vs. The Competition

MetricSQZ BiotechnologiesBiological Products IndustryMedical SectorNYSE Exchange
Market Cap$826K$286.93M$5.87B$21.64B
Dividend YieldN/AN/A5.68%3.49%
P/E Ratio-0.01N/A74.5229.75
Price / Sales0.05420.31518.9168.28
Price / CashN/A22.4437.5625.00
Price / Book0.0110.9112.164.58
Net Income-$79.46M-$111.61M$3.28B$1.00B
7 Day PerformanceN/A-0.19%0.78%0.65%
1 Month PerformanceN/A3.76%4.87%3.07%
1 Year PerformanceN/A-16.03%60.72%14.34%

SQZ Biotechnologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SQZ
SQZ Biotechnologies
N/A$0.03
flat
N/AN/A$826K$18.16M-0.011,620
CISS
C3is
0.9192 of 5 stars
$2.07
-1.9%
N/A-87.4%$1.92M$42.30M-0.12N/APositive News
OP
OceanPal
N/A$1.16
-1.3%
N/A-96.7%$346K$25.70M-0.0260Positive News
Short Interest ↓
GVH
Globavend
2.9757 of 5 stars
$4.18
-2.3%
$80.00
+1,813.9%
-96.4%$293K$16.54M0.007News Coverage
Gap Down
USDP
USD Partners
0.0458 of 5 stars
$0.01
-1.7%
N/A-50.4%$196K$72.32M-0.0190Gap Down
AIRTP
Air T
N/A$19.15
-0.5%
N/A+10.4%$0.00$296.31M0.00500Trending News
Short Interest ↓
BLDEW
Blade Air Mobility
N/A$0.18
+7.1%
N/A-10.5%$0.00$254.34M0.00130Positive News
Gap Up
RA
Brookfield Real Assets Income Fund
N/A$13.56
-0.2%
N/A-0.6%$0.00$67.52M-123.23N/AShort Interest ↓
EDRY
EuroDry
1.8855 of 5 stars
$11.06
+1.1%
N/A-41.0%$0.00$61.08M-2.13N/APositive News
HSHP
Himalaya Shipping
0.7575 of 5 stars
$8.23
-0.2%
N/A+14.4%$0.00$123.58M58.792Positive News
Dividend Increase
Gap Up
IMPPP
Imperial Petroleum
N/A$25.05
-1.4%
N/A+1.5%$0.00$127.68M0.00N/APositive News
Dividend Cut

Related Companies and Tools


This page (NYSE:SQZ) was last updated on 9/13/2025 by MarketBeat.com Staff
From Our Partners